Stefan Svensson Gelius

Stefan Svensson Gelius has a strong background in the pharmaceutical industry. Stefan started their career at Swedish Orphan Biovitrum in 2000, where they worked as a PhD Principal Scientist for 20 years. In 2020, they joined Oncopeptides AB as the Preclinical Development Director. Shortly after, they were promoted to Head of Research in September 2022.

Stefan Svensson Gelius attended Karolinska Institutet, although the specific start and end years of their education are unknown. The degree and field of study they pursued at the institution are also unspecified.